4-Bromo-6-(difluoromethyl)-7-(1-methyl-1H-pyrazol-4-yl)isoquinoline, 97%, 250mg

1,3-Di-tert-butylimidazol-2-ylidene>98.0%(T)1g

2-(4,4-DIMETHYL-4,5-DIHYDRO-2-OXAZOLYL)PYRIDINE, 95%, 1g

2,3-Dihydro-benzo[1,4]dioxine-2-carboxylic acid methyl ester, 95.0%, 10g

Dimethyl benzylphosphonate, 95.0%, 100g

Piperidine-2-carboxylic acid, 98.0%, 10g

3-Oxetanecarboxylic acid, 90.0%, 5g

3'-cyano-3-(3-methoxyphenyl)propiophenone, 97.0%, 1g

N-[(3S)-Pyrrolidin-3-yl]quinazolin-4-amine, 1g

1-(2-Chloro-benzyl)-3-nitro-1H-pyrazole, 5g

4-Ethoxy-3-methoxy-benzoic acid ethyl ester, 5g

2,7-Diacetylfluorene, 98.0%, 1g

Ester propylique d'acide 4-hydroxybenzoïque, min 98 %, Ph. Eur., USP, 100 g, emballage plastique.